coming to a conclusion

Chris Rief

Pfizer To Pay $486M To Settle Lawsuit Over Celebrex, Bextra

Pharma giant Pfizer has agreed to pay $486 million to close the books on a decade-long class-action securities lawsuit related to two of the company’s pain relievers, Celebrex and Bextra. [More]